Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( iii ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells
New Journal of Chemistry · 2026 · 50 (2) · 725-732
DOI: 10.1039/d5nj02700d ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Tai-ming Shao und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
This study aimed to develop a potential theranostic metal-containing drug for overcoming cisplatin (cisPt)-based resistance in A549/DDP lung cancer cells.
Förderung
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Shao, T., Liao, H., Li, Q., Tan, M., Liang, C., Liang, H., & Qin, Q. (2026). Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( iii ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells. New Journal of Chemistry, 50(2), 725-732. https://doi.org/10.1039/d5nj02700d
Vancouver
Shao T, Liao H, Li Q, Tan M, Liang C, Liang H, et al. Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( iii ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells. New Journal of Chemistry. 2026;50(2):725-732. doi:10.1039/d5nj02700d
BibTeX
@article{Shao2026,
author = {Shao, Tai-ming and Liao, Hai-Xia and Li, Qiu-Ming and Tan, Ming-Xiong and Liang, Chun-Jie and Liang, Hong and Qin, Qi-Pin},
title = {Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( iii ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells},
journal = {New Journal of Chemistry},
year = {2026},
volume = {50},
number = {2},
pages = {725--732},
doi = {10.1039/d5nj02700d}
}
EUVIMED